## 



## 

## 

|Trustees|||DT Hayes||||
|---|---|---|---|---|---|---|
||||P D BCornell||||
||||Dr G SDodge||||
||||Dr R Dwivadi||||
||||P Alionyte||lAppointed|27 October 2022)|
||||Drl Connolly||lAppointed|27 October 2022I|
|Charity number|||1179885||||
|Company|number||||||
|Registered||offioe|6 Hope Place||||
||||Liverpool||||
||||Me rseyside||||
||||Ll 9BG||||
|Independent||eseminer|Mitchell Charlesworth|(Audit) Limited|||
||||3rd Floor||||
||||STemple Square||||
||||Temple Street||||
||||Uverpool||||
||||Me rseyside||||
||||l2 SRH||||
|Bankers|||HSBC Bank pic||||
||||99-101Lord Street||||
||||liverpool||||
||||Ivleraeysi<br>de||||
||||L2 6PG||||





## 

|Trustees' report||
|---|---|
|Independent<br>erra miner's report||
|Statement<br>offinancial|activities|
|Balance sheet||
|Notes to the financial|statements|





## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

|||||Unrestricted|Restricted|Total|Vnrestrfcted|Nestrkted|Total|
|---|---|---|---|---|---|---|---|---|---|
|||||funds|funds||funds|funds||
|||||2022|2022|2022|2021|2021|2021|
||||Notes|6|6|6|||6|
|Income a|nd endearments||from:|||||||
|Donations|and|legacies|2|41,650|21,684|63,334|60,934|7,725|68,659|
|Other income|||3|9,102||9,102|1,281||1,281|
|Total Income||||50,752|21,684|72,436|62,215|7,725|69,940|
|~EEd~ii||||||||||
|Charitable|activities||4|51,737|24,304|76,041|58,32rl|2,895|61,219|
|Net Iexpendlturel/Income|||for|||||||
|the year/||||||||||
|Net rnovernent||In funds||(985)|(2,620)|I3,605)|3,891|4,830|8,721|
|Fund balances||at 1December||||||||
|2021||||32,394|5,663|38,057|28,503|833|29,336|
|Fund balances||at 30||||||||
|November|2022|||31,409||34,452|32,394|5,663|38,057|





## 

## 

## 

||||2022||2021||
|---|---|---|---|---|---|---|
||||8||8||
|Fixed assets|||||||
|Tangible assets||||4,882||4,597|
|Current<br>assets|||||||
|Debtors||10|5,048||5,402||
|Cash at bank and in|hand||26,483||33,540||
||||31,531||38,942||
|Creditorr: asnovnts|faging due within one||||||
|veal'|||(1,961)||(5,482)||
|Net current assets||||29,570||33,460|
|Total assets less current gebgitfes||||34,452||38,057|
|Income funds|||||||
|Itestricted funds||13||3,043||5,663|
|Unrestricted<br>funds||||31,409||32,394|
|||||34,452||38,057|






## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 




## 

## 

## 

|4|C ha rl table activities|C ha rl table activities|||||||
|---|---|---|---|---|---|---|---|---|
||||ARC5|Project POCV5 Ghana||Other|Total|Total|
|||||Malawi|||2022|2021|
||||2022|2022||2022|||
||||8|8||8|||
||Staff costs|||||||2,400|
||Consultancy|fees|2,881|638|2,690|2,835|9,044|5,036|
||Honors rlum||||298||298||
||Travel and subsistence||||10,492||10,492|12,925|
||Advertising|and marketing|||1,016||1,016||
||Training||240||7,816||8,056|763|
||Re8istration||||||||
||docume ntation|||1,266|||1,266||
||Insurance|||||||2,750|
||IT support|||1,337|||1,337||
||Other expenses|||17|1,159||1,176|3,344|
||||3,121|3,258|23,471|2,835|32,685|27,218|
||Share ofsupport costs||||||||
||(see note 5j||3,648|4,780|25,936|3,314|37,678|29,671|
||5hare ofgovernance costs||||||||
||(see note 5j||564|589|4,012|513|5,678|4,330|
||||7,333|8,627|53,419|6,662|76,041|61,219|
||Analysis<br>by|fund|||||||
||Vnrestricted|funds|5,687|7,653|31,735|6,662|51,737|58,324|
||Restricted funds||1,646|974|21,684||24,304|2,895|
||||7,333|8,627|53,419|6,662|76,041|61,219|





## 

## 

## 

|4|C ha rl table activities||||||(Conti nuedj|
|---|---|---|---|---|---|---|---|
||Forthe year ended 3D November|2D21||||||
||||ARCSa|Project POCUS Ghana||Other|Total|
|||||Mained|||2021|
|||||6|6||8|
||Staff costs||2,400||||2,4DD|
||Consultancy<br>fees||1,486||3,550||5,036|
||Travel<br>and<br>subsistence|||3,903|8,683|339|12,925|
||Training||||763||763|
||Insurance|||2,750|||2,750|
||Other expenses|||2,334|1,010||3,344|
||||3,886|8,987|14,006|339|27,218|
||Share ofsupport costs (see note|5)|4,235|9,797|15,269|370|29,671|
||Share ofgovernance costs (see note 5)||618|1,430|2,228|54|4,330|
||||8,739|20,214|31,503|763|61,219|
||Analysis<br>by fund|||||||
||Unrestricted<br>funds||6,252|19,806|31,503|763|58,324|
||Restricted funds||2,487|408|||2,895|
||||8,739|20,214|31,503|763|61,219|





## 

## 

## 

|5|Support costs|||||||||
|---|---|---|---|---|---|---|---|---|---|
||||Supportcosts|igove|manna|2022|Support costs|Bcwarnance|2021|
||||||costs|||costs||
||||||6||6|6||
||Staff costs||17,745|||17,745||||
||Depreciation||1,101|||1,101|273||273|
||Trave<br>I||1,464|||1,464|148||148|
||Subscript ions||498|||498|783||783|
||Administration|and||||||||
||marketing<br>support||14,240|||14,240|21,298||21,298|
||Office expenses||156|||156|415||415|
||Bank charges||149|||149|92||92|
||Other expenses||561|||561|718||718|
||Advertising<br>and|marketing|225|||225|96||96|
||IT software and|||||||||
||con su mables||1,539|||1,539|5,848||5,848|
||Legal and professional|||||||270|270|
||Independent<br>examination|||||||||
||fees||||1,800|1,800||1,542|1,542|
||Accountancy||||3,128|3,128||1,811|1,811|
||Trustee indemnity|||||||||
||insurance||||750|||707|707|
||||37,678||5,678|43,356|29,671|4,330|34,001|
||Analysed<br>between|||||||||
||Charitable<br>activities||37,678||5,678|43,356|29,671|4,330|34,001|





## 

## 

## 

|7|Employees|||IContlnuedI|
|---|---|---|---|---|
||Employment|costs|2D22|2D21|
||||E|E|
||Wages and salaries||17,388|2,4DD|
||Other pension costs||357||
||||17,745|2,400|



## 

## 

|9|Tangible gxed a|ssets||||||
|---|---|---|---|---|---|---|---|
||||||Medkal|Co ma ate re||
||||||equipment|||
||||||E|||
||Cost|||||||
||At 1December 2021||||3,829|1,041|4,870|
||Additions|||||1,386|1,386|
||At 30November|2022|||3,829|2,427|6,256|
||Depredation<br>and impairment|||||||
||At 1December 2D21||||221|52|273|
||Depreciation<br>charged||in the year||766|335|1,101|
||At 30November|Z022|||987|387|1,374|
||Carrying<br>amount|||||||
||At 30November|2022|||2,842|2,040|4,882|
||At 30November|Z021|||3,608|989|4,597|
|10|Debtors|||||||
|||||||2022|2021|
||Amounts<br>falling|due within||one year:||E|E|
||Other debtors|||||4,870|5,368|
||P repayments<br>and accrued|||income||178||
|||||||5,048|5,402|





## 

## 

## 

## 

|||2022|2021|
|---|---|---|---|
|||E|E|
|Trade creditors|||2,619|
|Other creditors||161||
|rsccruals and deferred|income|1,800|2,863|
|||1,961|5,482|



## 

## 



## 

## 

## 

## 

||||Movement|in funds||Movement|in funds||
|---|---|---|---|---|---|---|---|---|
|||aala neo at|Inmmlna|nasaurcsc|aslanm at|Inmrnlns|aasaum. c|balance at|
|||1December|rasa areas|axpan4 ad|1Dacembsr|racaurcas|axpandad|aa ttasambar|
|||lots|||lot1|||aaa2|
|African|||||||||
|Research|||||||||
|Consortium|on||||||||
|Sepsis (ARCS)||833|3.300|(2.487l|1.646||(1,646)||
|Ultrasound|||||||||
|equ<br>Ip ment|||||||||
|fund|||4,425|(408)|4,017||(974l|3,043|
|Bayer AG||||||18,000|(18,000l||
|Global|||||||||
|l'lacema nt|||||||||
|Bursanes for|||||||||
|Health|||||||||
|Partnerships||||||3,684|(3,684)||
|||833|7,725|(2,895l|5,663|21,684|(24,304l|3,043|



## 

|Analysis|of|net assets between|funds||||||
|---|---|---|---|---|---|---|---|---|
||||Unrestricted|Restricted|Total|Unrestricted|Restricted|Total|
||||funds|funds||funds|funds||
||||2022|2022||2021|2021|2021|
||||k|k||k|k|k|
|Fund balances at 30|||||||||
|November||2022 are|||||||
|represented||by:|||||||
|Tangible|assets||1,839|3,043|4,882|580|4,017|4,597|
|Current|assets/((labilities)||29,570||29,570|31,814|1,646|33,460|
||||31,409|3,043|34,452|32,394|5,663|38,057|





## 

## 

